RecruitingNCT07088991
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
Clinical and Demographic Characteristics of Adult Patients With NEurofibromatosis in RUSsia
Sponsor
AstraZeneca
Enrollment
200 participants
Start Date
Jun 6, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Clinical and Demographic Characteristics of Adult Patients with NEurofibromatosis in RUSsia (NEREUS)
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with neurofibromatosis. The study is currently recruiting participants at 14 locations.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07088991